Entrada Therapeutics · 5 hours ago
Senior Associate, Finance (CONTRACT)
Boston, MA
Contract
Hybrid
Mid, Senior Level
3+ years expEntrada Therapeutics is a clinical-stage biopharmaceutical company focused on transforming patient lives through innovative medicines. They are seeking a Senior Associate in Finance to support the FP&A team with budgeting, forecasting, financial modeling, and reporting, while collaborating closely with various business partners.
BiotechnologyEmergency MedicineGeneticsHealth CareMedical
Responsibilities
Planful experience strongly preferred. Experience with Anaplan or Adaptive acceptable if applicable
Be a superuser of the FP&A application, Planful, for data validation, financial modeling, variance analysis, and reporting
Help facilitate the overall company budgeting/forecasting (Communication of timelines and expectations, template creation and data loading, reporting summarized financials
Assist in formulating a cohesive and concise story around business drivers behind financial data and identifying potential risks and opportunities
Manage reporting of Cash vs. GAAP forecasting and comparisons to actuals
Support regular preparation of financial slides for leadership teams, audit committees, and board meetings
Support updates to financial models supporting the company long range plans and various strategic scenario plans
Develop reporting around Headcount and CapEx
Work cross functionally with R&D FP&A team in support of Planful initiatives including budget load functionality, reporting capabilities, and hierarchy structure
Partner with department leads to develop annual budgets, quarterly forecasts, and monthly estimates
Prepare & analyze monthly financial management reports, meet with business partners providing operational reviews, and discuss risks & opportunities to their forecasts
Approve expenditures in line with budget/forecast, validate proper coding on requisitions, and escalate issues as required
Be the single point of contact for department leads with all financial related matters
Support monthly close process, including accruals, as needed
Provide ad hoc financial analysis to business partners and influence best decision making through financial data and analytics
Qualification
Required
Bachelor's degree Finance/Accounting/Economics
Minimum 3+ years of progressive financial analysis experience
Experience with Planful or Adaptive systems
Financial statement knowledge and understanding of US GAAP
Strong business partnering skills
Strong presentation and communication skills
Ability to work effectively in a collaborative team environment and integrate multiple points of view to make informed decisions
Independently motivated, detail oriented and good problem-solving ability
Excellent organizational skills, with an ability to embrace change and multi-task in an extremely fast-paced environment
Excellent communications skills and ability to influence across multiple functions
Advanced level user in MS office, particularly Excel and Power Point, and financial systems, including Planful, NetSuite and similar systems
Preferred
Advanced degree preferred
Planful experience strongly preferred. Experience with Anaplan or Adaptive acceptable if applicable
Company
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
51-200 employees
H1B Sponsorship
Entrada Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (14)
2023 (4)
2022 (6)
2021 (1)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$301.6MKey Investors
Wellington Management
2024-06-24Post Ipo Equity· $100M
2022-12-08Post Ipo Equity· $26M
2021-10-29IPO
Leadership Team
Dipal Doshi
Chief Executive Officer
Leo Qian
Co-Founder
Recent News
2025-12-17
2025-11-22
2025-11-19
Company data provided by crunchbase